Join us at PepTalk 2024: Jan 16-19
Join us at booth #717 at PepTalk 2024 from January 16-19 in San Diego, CA! Dr. Frank An, Senior Director, Antibody Therapeutics will be presenting “Improving Anti-Tumor Activity with Bispecific Antibody Drug Conjugates” at 2:20 pm PST on Jan 19.
Whether you need humanized models, PK/PD services, or antibody discovery services, we’d love to partner with you to evaluate your novel immunotherapies. We have extensive experience testing novel monoclonal antibodies, bispecific antibodies, and cell-based therapies in our highly specialized models. Let us know how we can best assist you!
Presentation
Session: BISPECIFIC ADCs: A NEW FRONTIER
Presentation Title: Improving Anti-Tumor Activity with Bispecific Antibody Drug Conjugates
Speaker: Frank An, PhD., Senior Director, Antibody Therapeutics, Biocytogen Institute for Therapeutic Innovation
Time & Date: 2:20 pm PST, Jan 19, 2024
PepTalk provides a comprehensive program and innovative solutions for optimizing biotherapeutics. Conference tracks cover a range of topics including antibody engineering, bispecific antibody development, characterization of biologics, viral vector engineering, and protein expression platforms. (Source: PepTalk 2024 )
Event Date: January 16-19, 2024 | Event Location: San Diego, CA
